ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

March 7, 2021
Review
Open Access

Crosstalk between Different DNA Repair Pathways Contributes to Neurodegenerative Diseases.

Biology
Swapnil GuptaKulbhushan Sharma
March 7, 2021
Review
Open Access

The Role of the Inflammasome in Neurodegenerative Diseases.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Federica PianconeMario Clerici
March 7, 2021
Review
Open Access

Mast Cell and Astrocyte Hemichannels and Their Role in Alzheimer's Disease, ALS, and Harmful Stress Conditions.

International Journal of Molecular Sciences
Paloma A HarchaBrigitte van Zundert
March 5, 2021
Review
Open Access

Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies.

Faculty Reviews
Lauren M Gittings, Rita Sattler
March 4, 2021
Review

Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation.

Nature Reviews. Neuroscience
Paraskevi TziortzoudaFrank Hirth
March 4, 2021

The emerging role of the chondroitin sulfate proteoglycan family in neurodegenerative diseases.

Reviews in the Neurosciences
Jia-Zhe LinWei-Jiang Zhao
March 2, 2021
Preprint
Open Access

Compositional analysis of ALS-linked stress granule-like structures reveals factors and cellular pathways dysregulated by mutant FUS under stress

BioRxiv : the Preprint Server for Biology
Taty AnTatyana A Shelkovnikova
March 2, 2021
Open Access

Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS.

Frontiers in Molecular Neuroscience
Ya-Fei ZhaoPeter Illes
February 28, 2021
Review

Mitochondrial Dysfunction and Traffic Jams in Amyotrophic Lateral Sclerosis.

Mitochondrion
Rishabh JhanjiSimona Bungau
February 25, 2021

Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in Japan.

Journal of Neurology
Rino InadaSusumu Kusunoki
February 25, 2021

Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis.

Cellular and Molecular Neurobiology
Ursula MuñozMari Cruz Sadaba
February 24, 2021
Open Access

Gastrointestinal biopsies and amyotrophic lateral sclerosis - results from a cohort study of 1.1 million individuals.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Jiangwei SunFang Fang
February 23, 2021
Open Access

The multi-faceted role of mitochondria in the pathology of Parkinson's disease.

Journal of Neurochemistry
Dennison TrinhJoanne E Nash
February 21, 2021
Review

Implication of post-translationally modified SOD1 in pathological aging.

GeroScience
Kashfia ShafiqJiming Kong
February 20, 2021
Open Access

No association of GSTP1 rs1695 polymorphism with amyotrophic lateral sclerosis: A case-control study in the Brazilian population.

PloS One
Jéssica Barletto de Sousa BarrosAngela Adamski da Silva Reis
February 16, 2021
Open Access

Mitochondrial Redox Signaling Is Critical to the Normal Functioning of the Neuronal System.

Frontiers in Cell and Developmental Biology
Olena OdnokozSvetlana N Radyuk
February 16, 2021
Review
Open Access

The role of immune-mediated alterations and disorders in ALS disease.

Human Immunology
João Rodrigues Lima-JuniorAlessandro Sette

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

© 2021 Meta ULC. All rights reserved
/feed-previews/als-pathogenic-mechanisms/1e2f6567-a7ae-4de0-a163-383117313513